Source: Letters in Drug Design and Discovery. Unidade: IFSC
Subjects: FÁRMACOS, PRODUTOS NATURAIS, DOENÇAS INFECCIOSAS, DOENÇAS (TRATAMENTO), LIGANTES
ABNT
COSTA, Fernanda C. et al. Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents. Letters in Drug Design and Discovery, v. 5, n. 3, p. 158-161, 2008Tradução . . Disponível em: https://doi.org/10.2174/157018008784083956. Acesso em: 21 ago. 2024.APA
Costa, F. C., Nicoluci, R. P., Silva, M., Rocha, W. C., Vieira, P. C., Oliva, G., et al. (2008). Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents. Letters in Drug Design and Discovery, 5( 3), 158-161. doi:10.2174/157018008784083956NLM
Costa FC, Nicoluci RP, Silva M, Rocha WC, Vieira PC, Oliva G, Thiemann OH, Andricopulo AD. Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents [Internet]. Letters in Drug Design and Discovery. 2008 ; 5( 3): 158-161.[citado 2024 ago. 21 ] Available from: https://doi.org/10.2174/157018008784083956Vancouver
Costa FC, Nicoluci RP, Silva M, Rocha WC, Vieira PC, Oliva G, Thiemann OH, Andricopulo AD. Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents [Internet]. Letters in Drug Design and Discovery. 2008 ; 5( 3): 158-161.[citado 2024 ago. 21 ] Available from: https://doi.org/10.2174/157018008784083956